BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23803252)

  • 21. Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.
    He Y; Gong Y; Lin J; Chang DW; Gu J; Roth JA; Wu X
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):443-51. PubMed ID: 23300022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
    Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
    Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment.
    Bourton EC; Plowman PN; Smith D; Arlett CF; Parris CN
    Int J Cancer; 2011 Dec; 129(12):2928-34. PubMed ID: 21491423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodosimetry Based on γ-H2AX Quantification and Cytogenetics after Partial- and Total-Body Irradiation during Fractionated Radiotherapy.
    Zahnreich S; Ebersberger A; Kaina B; Schmidberger H
    Radiat Res; 2015 Apr; 183(4):432-46. PubMed ID: 25844946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Honey-Lemon Spray Versus Benzydamine Hydrochloride Spray on Radiation-Induced Acute Oral Mucositis in Head and Neck Cancer Patients: A Pilot, Randomized, Double-Blind, Active-Controlled Clinical Trial.
    Ameri A; Poshtmahi S; Heydarirad G; Cramer H; Choopani R; Hajimehdipoor H; Azghandi S; Pasalar M
    J Altern Complement Med; 2021 Mar; 27(3):255-262. PubMed ID: 33512251
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction of late adverse events in pelvic cancer patients receiving definitive radiotherapy using radiation-induced gamma-H2AX foci assay.
    Someya M; Hasegawa T; Nakamura AJ; Tsuchiya T; Kitagawa M; Gocho T; Mafune S; Ikeuchi Y; Tauchi H; Sakata KI
    J Radiat Res; 2023 Nov; 64(6):948-953. PubMed ID: 37839163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
    J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
    Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
    Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.
    Lobachevsky P; Leong T; Daly P; Smith J; Best N; Tomaszewski J; Thompson ER; Li N; Campbell IG; Martin RF; Martin OA
    Cancer Lett; 2016 Dec; 383(2):212-219. PubMed ID: 27693457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report.
    Xanthinaki A; Nicolatou-Galitis O; Athanassiadou P; Gonidi M; Kouloulias V; Sotiropoulou-Lontou A; Pissakas G; Kyprianou K; Kouvaris J; Patsouris E
    Support Care Cancer; 2008 Sep; 16(9):1025-33. PubMed ID: 18197435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
    Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
    Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
    Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
    Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ratio of γ-H2AX level in lymphocytes to that in granulocytes detected using flow cytometry as a potential biodosimeter for radiation exposure.
    Wang Z; Hu H; Hu M; Zhang X; Wang Q; Qiao Y; Liu H; Shen L; Zhou P; Chen Y
    Radiat Environ Biophys; 2014 May; 53(2):283-90. PubMed ID: 24687842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs).
    Bordón E; Henríquez-Hernández LA; Lara PC; Ruíz A; Pinar B; Rodríguez-Gallego C; Lloret M
    Radiat Oncol; 2010 Jan; 5():4. PubMed ID: 20109191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of early nutritional intervention on oral mucositis and basic conditions in patients receiving radiotherapy for head and neck cancer: Randomized controlled trial (ChiCTR2000031418).
    Wei J; Chen Y; Su J; Zhao Q; Wang H; Zheng Z; Wu J; Jiang X
    Clin Nutr; 2024 Jul; 43(7):1717-1723. PubMed ID: 38833872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy.
    Jehmlich N; Stegmaier P; Golatowski C; Salazar MG; Rischke C; Henke M; Völker U
    J Proteomics; 2015 Jul; 125():98-103. PubMed ID: 25997676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of 177Lu-DOTA-octreotate therapy-induced DNA damage in peripheral blood lymphocytes of patients with neuroendocrine tumors.
    Denoyer D; Lobachevsky P; Jackson P; Thompson M; Martin OA; Hicks RJ
    J Nucl Med; 2015 Apr; 56(4):505-11. PubMed ID: 25722453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.